Drug archive
Ribavirin (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antiviral, systemic
Description
Ribavirin (rye-ba-VYE-rin) is used to treat severe virus pneumonia in infants and young children. It is given by oral inhalation (breathing in the medicine as a fine mist through the mouth), using a special nebulizer (sprayer) attached to an oxygen hood or tent or face mask.
Ribavirin taken by mouth (oral) treats a viral liver infection known as hepatitis C. It is used in combination with injectable interferon alfa-2b (in-ter-FEER-on AL-fa-2b) or with injectable peginterferon alfa-2b (peg-in-ter-FEER-on AL-fa-2b). Ribavirin is used to treat virus infections. Interferons are substances naturally produced by cells in the body to help fight infections and tumors. Interferon alfa-2b and peginterferon alfa-2b are synthetic (man-made) versions of these substances. Interferon alfa-2b and peginterferon alfa-2b are used to treat a variety of tumors and viruses including the hepatitis C virus.
Ribavirin is available in the following dosage forms:
- For inhalation solution (U.S. and Canada)
- Capsules (U.S.)
- Oral solution (U.S.)
- Tablets (U.S.)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Copegus
- Rebetol
- Virazole
In Canada -
- Virazole
Another commonly used name is tribavirin .